Subjects -> MEDICAL SCIENCES (Total: 8697 journals)
    - ALLERGOLOGY AND IMMUNOLOGY (220 journals)
    - ANAESTHESIOLOGY (121 journals)
    - CARDIOVASCULAR DISEASES (338 journals)
    - CHIROPRACTIC, HOMEOPATHY, OSTEOPATHY (21 journals)
    - COMMUNICABLE DISEASES, EPIDEMIOLOGY (235 journals)
    - DENTISTRY (294 journals)
    - DERMATOLOGY AND VENEREOLOGY (163 journals)
    - EMERGENCY AND INTENSIVE CRITICAL CARE (124 journals)
    - ENDOCRINOLOGY (151 journals)
    - FORENSIC SCIENCES (42 journals)
    - GASTROENTEROLOGY AND HEPATOLOGY (189 journals)
    - GERONTOLOGY AND GERIATRICS (138 journals)
    - HEMATOLOGY (158 journals)
    - HYPNOSIS (4 journals)
    - INTERNAL MEDICINE (178 journals)
    - LABORATORY AND EXPERIMENTAL MEDICINE (99 journals)
    - MEDICAL GENETICS (58 journals)
    - MEDICAL SCIENCES (2419 journals)
    - NURSES AND NURSING (371 journals)
    - OBSTETRICS AND GYNECOLOGY (208 journals)
    - ONCOLOGY (386 journals)
    - OPHTHALMOLOGY AND OPTOMETRY (141 journals)
    - ORTHOPEDICS AND TRAUMATOLOGY (170 journals)
    - OTORHINOLARYNGOLOGY (83 journals)
    - PATHOLOGY (100 journals)
    - PEDIATRICS (275 journals)
    - PHYSICAL MEDICINE AND REHABILITATION (159 journals)
    - PSYCHIATRY AND NEUROLOGY (834 journals)
    - RADIOLOGY AND NUCLEAR MEDICINE (192 journals)
    - RESPIRATORY DISEASES (105 journals)
    - RHEUMATOLOGY (79 journals)
    - SPORTS MEDICINE (81 journals)
    - SURGERY (406 journals)
    - UROLOGY, NEPHROLOGY AND ANDROLOGY (155 journals)

UROLOGY, NEPHROLOGY AND ANDROLOGY (155 journals)                     

Showing 1 - 155 of 155 Journals sorted alphabetically
Acta Urológica Portuguesa     Open Access   (Followers: 1)
Actas Urológicas Españolas     Full-text available via subscription   (Followers: 3)
Actas Urológicas Españolas (English Edition)     Full-text available via subscription   (Followers: 1)
Advances in Chronic Kidney Disease     Full-text available via subscription   (Followers: 11)
Advances in Urology     Open Access   (Followers: 13)
African Journal of Nephrology     Open Access  
African Journal of Urology     Open Access   (Followers: 7)
AJP Renal Physiology     Hybrid Journal   (Followers: 8)
Aktuelle Urologie     Hybrid Journal   (Followers: 11)
American Journal of Kidney Diseases     Hybrid Journal   (Followers: 42)
American Journal of Men's Health     Open Access   (Followers: 9)
American Journal of Nephrology     Full-text available via subscription   (Followers: 36)
Andrologia     Hybrid Journal   (Followers: 2)
Andrology     Hybrid Journal   (Followers: 4)
Andrology & Gynecology : Current Research     Hybrid Journal   (Followers: 4)
Andrology and Genital Surgery     Open Access   (Followers: 7)
Andrology-Open Access     Open Access  
Annales d'Urologie     Full-text available via subscription  
Arab Journal of Nephrology and Transplantation     Open Access   (Followers: 1)
Arab Journal of Urology     Open Access   (Followers: 7)
Archives of Clinical Nephrology     Open Access   (Followers: 2)
Archivio Italiano di Urologia e Andrologia     Open Access   (Followers: 1)
Archivos Españoles de Urología     Open Access  
Asian Journal of Andrology     Open Access   (Followers: 1)
Asian Journal of Urology     Open Access   (Followers: 3)
Bangladesh Journal of Urology     Open Access   (Followers: 5)
BANTAO Journal     Open Access  
Basic and Clinical Andrology     Open Access  
BJU International     Hybrid Journal   (Followers: 35)
BMC Nephrology     Open Access   (Followers: 9)
BMC Urology     Open Access   (Followers: 15)
Canadian Journal of Kidney Health and Disease     Open Access   (Followers: 6)
Canadian Urological Association Journal     Open Access   (Followers: 2)
Cancer Urology     Open Access   (Followers: 2)
Cardiorenal Medicine     Full-text available via subscription   (Followers: 1)
Case Reports in Nephrology     Open Access   (Followers: 5)
Case Reports in Nephrology and Dialysis     Open Access   (Followers: 9)
Case Reports in Urology     Open Access   (Followers: 12)
Clinical and Experimental Nephrology     Hybrid Journal   (Followers: 4)
Clinical Journal of the American Society of Nephrology     Full-text available via subscription   (Followers: 19)
Clinical Medicine Insights : Urology     Open Access   (Followers: 3)
Clinical Nephrology     Full-text available via subscription   (Followers: 8)
Clinical Nephrology and Urology Science     Open Access   (Followers: 6)
Clinical Queries: Nephrology     Hybrid Journal   (Followers: 1)
Cuadernos de Cirugía     Open Access   (Followers: 3)
Current Opinion in Nephrology & Hypertension     Hybrid Journal   (Followers: 10)
Current Opinion in Urology     Hybrid Journal   (Followers: 12)
Current Urology     Open Access   (Followers: 10)
Current Urology Reports     Hybrid Journal   (Followers: 5)
Der Nephrologe     Hybrid Journal  
Der Urologe     Hybrid Journal   (Followers: 7)
EMC - Urología     Full-text available via subscription  
Enfermería Nefrológica     Open Access   (Followers: 1)
European Urology     Full-text available via subscription   (Followers: 38)
European Urology Focus     Hybrid Journal   (Followers: 6)
European Urology Supplements     Full-text available via subscription   (Followers: 15)
Forum Nefrologiczne     Full-text available via subscription  
Geriatric Nephrology and Urology     Hybrid Journal   (Followers: 7)
Giornale di Clinica Nefrologica e Dialisi     Open Access  
Herald Urology     Open Access   (Followers: 2)
Hong Kong Journal of Nephrology     Open Access   (Followers: 3)
Human Andrology     Partially Free   (Followers: 2)
IJU Case Reports     Open Access  
Indian Journal of Nephrology     Open Access   (Followers: 2)
Indian Journal of Urology     Open Access   (Followers: 5)
International Brazilian Journal of Urology     Open Access   (Followers: 5)
International Journal of Nephrology     Open Access   (Followers: 2)
International Journal of Nephrology and Renovascular Disease     Open Access   (Followers: 2)
International Journal of Urology     Hybrid Journal   (Followers: 12)
International Urology and Nephrology     Hybrid Journal   (Followers: 7)
Jornal Brasileiro de Nefrologia     Open Access  
Journal für Urologie und Urogynäkologie/Österreich     Hybrid Journal  
Journal of Clinical Nephrology     Open Access   (Followers: 1)
Journal of Clinical Urology     Hybrid Journal   (Followers: 14)
Journal of Endoluminal Endourology     Open Access  
Journal of Endourology     Hybrid Journal   (Followers: 2)
Journal of Endourology Case Reports     Hybrid Journal  
Journal of Genital System & Disorders     Hybrid Journal   (Followers: 3)
Journal of Integrative Nephrology and Andrology     Open Access   (Followers: 2)
Journal of Kidney Cancer and VHL     Open Access  
Journal of Lower Genital Tract Disease     Hybrid Journal  
Journal of Nephrology     Hybrid Journal   (Followers: 4)
Journal of Nephrology Research     Open Access   (Followers: 3)
Journal of Pediatric Nephrology     Open Access   (Followers: 3)
Journal of Renal Care     Hybrid Journal   (Followers: 8)
Journal of Renal Nursing     Full-text available via subscription   (Followers: 12)
Journal of Renal Nutrition     Hybrid Journal   (Followers: 28)
Journal of Renal Nutrition and Metabolism     Open Access   (Followers: 1)
Journal of the American Society of Nephrology     Full-text available via subscription   (Followers: 27)
Journal of The Egyptian Society of Nephrology and Transplantation     Open Access  
Journal of Translational Neurosciences     Open Access  
Journal of Urology     Full-text available via subscription   (Followers: 53)
Journal of Urology & Nephrology     Open Access   (Followers: 2)
Kidney Disease and Transplantation     Open Access   (Followers: 4)
Kidney Diseases     Open Access   (Followers: 3)
Kidney International     Hybrid Journal   (Followers: 44)
Kidney International Reports     Open Access   (Followers: 3)
Kidney Medicine     Open Access  
Kidney Research Journal     Open Access   (Followers: 6)
Kidneys (Počki)     Open Access   (Followers: 1)
Nature Reviews Nephrology     Full-text available via subscription   (Followers: 19)
Nature Reviews Urology     Full-text available via subscription   (Followers: 13)
Nefrología (English Edition)     Open Access  
Nefrología (Madrid)     Open Access  
Nephro-Urology Monthly     Open Access   (Followers: 1)
Nephrology     Hybrid Journal   (Followers: 12)
Nephrology Dialysis Transplantation     Hybrid Journal   (Followers: 25)
Nephron     Hybrid Journal   (Followers: 4)
Nephron Clinical Practice     Full-text available via subscription   (Followers: 4)
Nephron Experimental Nephrology     Full-text available via subscription   (Followers: 4)
Nephron Extra     Open Access   (Followers: 1)
Nephron Physiology     Full-text available via subscription   (Followers: 4)
Neurourology and Urodynamics     Hybrid Journal   (Followers: 1)
OA Nephrology     Open Access   (Followers: 2)
Open Access Journal of Urology     Open Access   (Followers: 6)
Open Journal of Nephrology     Open Access   (Followers: 5)
Open Journal of Urology     Open Access   (Followers: 7)
Open Urology & Nephrology Journal     Open Access  
Pediatric Urology Case Reports     Open Access   (Followers: 7)
Portuguese Journal of Nephrology & Hypertension     Open Access   (Followers: 1)
Progrès en Urologie     Full-text available via subscription  
Progrès en Urologie - FMC     Full-text available via subscription  
Prostate Cancer and Prostatic Diseases     Hybrid Journal   (Followers: 6)
Renal Failure     Open Access   (Followers: 12)
Renal Replacement Therapy     Open Access   (Followers: 4)
Research and Reports in Urology     Open Access   (Followers: 4)
Revista de Nefrología, Diálisis y Trasplante     Open Access   (Followers: 1)
Revista Mexicana de Urología     Open Access   (Followers: 1)
Revista Urologia Colombiana     Open Access  
Saudi Journal of Kidney Diseases and Transplantation     Open Access   (Followers: 2)
Scandinavian Journal of Urology     Hybrid Journal   (Followers: 8)
Seminars in Nephrology     Hybrid Journal   (Followers: 11)
The Prostate     Hybrid Journal   (Followers: 8)
Therapeutic Advances in Urology     Open Access   (Followers: 4)
Trends in Urology & Men's Health     Partially Free   (Followers: 1)
Ukrainian Journal of Nephrology and Dialysis     Open Access   (Followers: 1)
Uro-News     Hybrid Journal   (Followers: 2)
Urolithiasis     Hybrid Journal   (Followers: 2)
Urologia Internationalis     Full-text available via subscription   (Followers: 2)
Urologia Journal     Hybrid Journal  
Urologic Clinics of North America     Full-text available via subscription   (Followers: 4)
Urologic Nursing     Full-text available via subscription   (Followers: 4)
Urologic Radiology     Hybrid Journal  
Urological Science     Open Access  
Urologicheskie Vedomosti     Open Access  
Urologie in der Praxis     Hybrid Journal  
Urologie Scan     Hybrid Journal  
Urology     Hybrid Journal   (Followers: 34)
Urology Annals     Open Access   (Followers: 4)
Urology Case Reports     Open Access   (Followers: 3)
Urology Practice     Full-text available via subscription   (Followers: 2)
Urology Times     Free   (Followers: 3)
Urology Video Journal     Open Access   (Followers: 1)
World Journal of Nephrology and Urology     Open Access   (Followers: 15)
World Journal of Urology     Hybrid Journal   (Followers: 12)

           

Similar Journals
Journal Cover
Kidneys (Počki)
Number of Followers: 1  

  This is an Open Access Journal Open Access journal
ISSN (Print) 2307-1257 - ISSN (Online) 2307-1265
Published by Publishing House Zaslavsky Homepage  [9 journals]
  • Appeal of Editor-in-Chief

    • Authors: D.D. Ivanov
      First page: 1
      Abstract: No abstract
      PubDate: 2020-02-01
      Issue No: Vol. 9, No. 1 (2020)
       
  • To the World Kidney Day 2020. Kidney diseases — let’s be
           aware!

    • Authors: No authors .
      Pages: 2 - 3
      Abstract: No abstract
      PubDate: 2020-01-01
      Issue No: Vol. 9, No. 1 (2020)
       
  • Perspective of personalized treatment of immunoglobulin A-nephropathy

    • Authors: K.S. Komissarov
      Pages: 4 - 9
      Abstract: The search of personalized treatment for a subject with immunoglobulin A-nephropathy (IgAN) attracts attention of nephrologists all over the world. According to the Kidney Di­sease: Improving Global Outcomes guidelines, persistentprotei­nuria > 1 g/day for 3–6 months despite optimized supportive care is considered as indication to corticosteroid/immunosuppressive treatment in IgAN patients. The Oxford classification study and subsequent investigations have revealed the value of pathologic risk factors in disease progression regardless of proteinuria, blood pressure level and glomerular filtration rate at renal biopsy. Meanwhile, new studies have provided an improved understanding of the pathogenetic mechanisms leading to kidney tissue damage in IgAN. This review provides the possibility of using treatment based on pathological changes in the individual patient with IgAN, taking into consideration the pathogenetic mechanisms prevailing at the time of renal biopsy.
      PubDate: 2020-01-01
      Issue No: Vol. 9, No. 1 (2020)
       
  • Hydration: the review of 3 trials

    • Authors: D. Ivanov, M. Ivanova
      Pages: 10 - 13
      Abstract: The concepts of forced hydration and excessive forced hydration are discussed in the article. The authors emphasize that excessive forced hydration has a proven track record in improving the quali­ty of life for dehydrated people. In case of normovolemia, there is no evidence of quality improvement and prolongation of life when excessive forced hydration is used. The issue of forced hydration in chronic kidney disease (CKD) is considered separately. Three randomized clinical trials were analyzed in which patients with CKD stage 1–2, 3 and 4–5 received forced hydration. The results of studies indicate the possible efficacy of forced hydration in stage 1–2 CKD in patients with normal or increased renal functional reserve. In stage 3 CKD, forced hydration showed no benefits, and in stage 4–5 CKD, it resulted in greater renal function loss. Summarizing these data, the authors concluded that it is probably appropriate for healthy people to consume the amount of fluid that provides physiological diuresis of 1.2–1.8 L and normal urine osmolarity. Forced hydration is often excessive, excessive forced hydration may not promote a healthy lifestyle. Forced hydration becomes excessive forced hydration as kidney function decreases. Possibly, the benefits of forced hydration are lost in CKD with progression of renal function loss. The effect of forced hydration for 12 months may be positive in stage 1 CKD and stage 2 CKD with normal renal functional reserve. Forced hydration is probably inexpedient in chronic stages 3–5.
      PubDate: 2020-01-01
      Issue No: Vol. 9, No. 1 (2020)
       
  • Impaired endothelial vasoregulatory function in patients with systemic
           lupus erythematosus: association with renal involvement, inflammatory
           markers, and autoantibodies

    • Authors: I.G. Matiyashchuk, K.M. Amosova, O.B. Iaremenko, V.I. Zakharova, D.I. Koliadenko
      Pages: 14 - 19
      Abstract: Background. The leading cause of death in patients with systemic lupus erythematosus (SLE) is cardiovascular diseases due to early atherosclerosis. Endothelial dysfunction is considered one of the markers of subclinical atherosclerosis. The work aimed at assessing the endothelial vasoregulatory function in patients with SLE and its relationship with clinical and laboratory features of SLE. Materials and methods. We studied endothelium-dependent (EDVD) and endothelium-independent vasodilation (EIVD) of the brachial artery in 100 patients with SLE. Results. EDVD in patients with SLE was reduced by an average of 31.5 % compared with healthy individuals (p < 0.001). The average va­lues of EIVD in the group of patients with SLE (20.03 ± 0.80 %) and in the group of healthy individuals (21.4 ± 0.7 %) did not significantly differ (p > 0.05). The presence of lupus nephritis was associated with a significant deterioration in EDVD (42.5 % compared with the control group and 25.8 % compared with the alternative group, p < 0.001 and p < 0.05, respectively). The ave­rage values of EDVD in patients with elevated levels of C-reactive protein (CRP) were reduced by 35.1 % compared with the control group (p < 0.001), and in patients with normal levels of CRP — by 25.9 % (p < 0.001; the difference between the subgroups is unreliable). No significant correlation between the values of CRP and EDVD was found (r = 0.10, p > 0.05). In patients with positive antinuclear factor (ANF) and antibodies to native DNA (anti-nDNA), the values of EDVD were 32.0 and 35.2 % lower, respectively, than in the control group (p < 0.001). At the same time, in patients with negative ANF and anti-nDNA, the difference with the control group was unreliable (p > 0.05). According to the results of multiple linear regression analysis, the independent determinants of EDVD were the patient’s age (p < 0.001), the pre­sence of nephritis (regardless of its form) (p = 0.001), polyarthritis (p = 0.019), and Raynaud’s syndrome (p = 0.045). Conclusions. SLE patients have impaired vasoregulatory function of the endothelium, especially in the presence of lupus nephritis, elevated titers of ANF and anti-nDNA. EDVD does not correlate with CRP level in patients with SLE.
      PubDate: 2020-01-01
      Issue No: Vol. 9, No. 1 (2020)
       
  • Clinical assessment of disorders of the melatonin-forming function of the
           pineal gland and anemia in patients with chronic kidney disease stage 5
           undergoing hemodialysis

    • Authors: V.E. Kondratiuk, A.S. Petrova, O.V. Karpenko
      Pages: 20 - 28
      Abstract: Background. The results of a number of studies have proved the relationship between the functional state of the pineal gland and renal function. However, violations of the melatonin-forming function (MFF) of the pineal gland in patients with chronic kidney disease (CKD) undergoing hemodialysis and its relationship with the development of anemia in this population is a poorly understood issue. The purpose: to conduct a clinical assessment of anemia in patients with stage 5 CKD who are treated with hemodialysis depending on clinical and demographic parameters, and to determine its correlation with the violation of MFF. Materials and methods. We examined 130 people (50 % of men) with stage 5 CKD undergoing hemodialysis treatment. Based on the level of melatonin in saliva, patients treated with hemodialysis were divided into two groups: group I — 110 individuals with impaired MFF, group II — 20 people with normal MFF. The control group included 20 healthy individuals matched for age and gender. All patients underwent clinical and laboratory studies: general and biochemical blood tests with determination of all indicators of blood iron metabolism, lipid profile, blood pressure measurement, body mass index calculation, evaluation of the salivary melatonin concentration at different periods of the day, as well as parathyroid hormone. Results. A significant prevalence of MFF disturbance was found in patients with stage 5 CKD, which are treated with hemodialysis, and its relationship with the development of anemia. Analysis of circadian melatonin levels depending on the severity of anemia demonstrated their profound impairment in patients with mode­rate severity of anemia, in which a significant difference was determined by the level of melatonin at night (p = 0.004). Correlation analysis showed a weak negative correlation between the level of hemoglobin and the duration of hemodialysis (r = –0.217; p < 0.05) that may indicate the progression of anemia with an increase in the duration of renal replacement treatment. Positive correlations were established between hemoglobin concentration and the level of daytime melatonin (r = 0.193; p < 0.05), and closer relationship — with the level of nighttime melatonin (r = 0.278; p < 0.05), which reflects the correlation between the violation of MFF and hemoglobin synthesis. A negative correlation was demonstrated between ferritin and hemoglobin level (r = –0.31; p < 0.05), as well as with serum iron concentration (r = –0.202; p < 0.05) and the level of transferrin (r = –0.234; p < 0.05). A negative correlation is determined between the level of ferritin and the daytime salivary melatonin (r = –0.202; p < 0.05), and the relationship of average strength — with salivary melatonin at night (r = –0.396; p < 0.05). When analyzing the level of transferrin, we determined the positive correlation of the latter with the daytime melatonin (r = –0.332; p < 0.05), and average correlation — with melatonin level at night (r = 0.447; p < 0.05). The inverse weak correlation was found between transferrin concentration and hemodialysis duration (r = –0.191; p < 0.05). Conclusions. A high frequency of MFF disturbance was demonstrated (84.6 %), which is associated with a significant prevalence of anemia and iron deficiency in patients with stage 5 CKD undergoing hemodialysis treatment. In people receiving renal replacement treatment, a relationship was established between the degree of pineal gland dysfunction and the severity of anemia; at that, it increases with an increase in the duration of hemodialysis treatment and the duration of hypertension. In hemodialysis patients, the concentration of ferritin reflects the activity of inflammation that increases with a violation of MFF. Pineal gland dysfunction and anemia have age-dependent nature: they are most severe in old age.
      PubDate: 2020-01-01
      Issue No: Vol. 9, No. 1 (2020)
       
  • The prognostic significance of sex and age of the child in the urinary
           tract infection and the formation of the nature of its course

    • Authors: T.V. Budnik
      Pages: 29 - 34
      Abstract: Background. The study of new and management of proven risk factors for urinary tract infection (UTI) in children is of particular relevance in the current conditions of globalization of society. The purpose: to study the features of the prevalence of UTI in children, depending on the gender and age of the patient, and to assess the prognostic significance of these factors in UTI, influence on the nature of its course. Materials and methods. Two thousand six hundred and fifty-eight children with UTI aged 1 month to 18 years participated in the study. Patients’ screening and evaluation of the data were conducted with the informed consent of children, their parents, and by following the Declaration of Human Rights of Helsinki. The study design suggested the distribution of patients by gender and age. The age groups were defined as: < 1 year, 1–3, 4–6, 7–12, and 13–18 years. Statistical analysis of the dependence of the UTI on the age and gender was performed by evaluating indicators using the relative risk (RR). Results. It was found that RR of UTI in boys under 1 year of age was 2.3 times higher than in girls (2.318 ± 0.261 (1.395; 3.852) vs 0.433 ± 0.260 (0.260; 0.717), p < 0.05). In adolescence, RR of UTI in girls and boys was almost equal (1.108 ± 0.290 (0.623; 1.970) vs 0.903 ± 0.290 (0.508; 1.605), p > 0.05). The RR of chronic pyelonephritis in boys was significantly higher — by 2.4 times (2.426 ± 0.230 (1.551; 3.795) vs 0.412 ± 0.230 (0.264; 0.645), p < 0.05). Girls had 2.2 times higher RR of chronic cystitis (2.19 ± 0.43 (0.951; 5.044) vs 0.457 ± 0.430 (0.198; 1.051), p > 0.05) and 1.7 times higher — of acute pyelonephritis (1.744 ± 0.210 (1.163; 2.615) vs 0.573 ± 0.210 (0.382; 0.860), p < 0.05). In general, girls had a hundred-fold higher RR of UTI (682.382 ± 0.146 (513.003; 907.69) vs 0.001 ± 0.146 (0.001; 0.002), p < 0.05), but boys had a 1.5 times higher RR of recurrent UTI (1.526 ± 0.210 (1.018; 2.286) vs 0.655 ± 0.206 (0.437; 0.982), p < 0.05). Conclusions. Gender and age of the child as factors of influence had prognostic significance for the likelihood and relative risk of UTI, as well as for the formation of the nature of the disease.
      PubDate: 2020-01-01
      Issue No: Vol. 9, No. 1 (2020)
       
  • High doses of torasemide in the doctor’s practice: obvious benefits

    • Authors: D.D. Ivanov
      Pages: 35 - 38
      Abstract: Today, torasemide is the most prescribed loop diuretic in clinical practice. Its high doses are used mainly in two clinical situations accompanied by hyperhydration: chronic heart failure (CHD) and chronic kidney disease (CKD). The latest guidelines on CHD management, 2019, have defined a clear algorithm for the use of large doses of torasemide, given that the large doses have a lasting diuretic effect. The daily dose is in the range of 50–300 mg of torasemide per day, prescribed continuously and for a long time. The clinical practice evidence demonstrates a high level of natriuretic peptide B to be usually accompanied by a large diuresis. With CKD, large doses of torasemide are in the range of 40–100 mg (200 mg) per day. Given the limitations of the renal water function, which increases proportionally with the degree of CKD, the mode and efficacy of torasemide is different from CHD. With CKD, torasemide is prescribed in doses up to 100 mg 6 days a week, the seventh is a break. When using doses of 100–200 mg, torasemide is prescribed for two days of intake — two days of break. Large doses of torasemide demonstrate high efficacy in reducing/eliminating hyperhydration in CHD and CKD. Their long-term administration reduces overall and cardiovascular mortality rates. The effect of torasemide is enhanced by the simultaneous administration of xipamide. The combination of torasemide and furosemide was determined to be impractical.
      PubDate: 2020-01-01
      Issue No: Vol. 9, No. 1 (2020)
       
  • Hyperphosphatemia is a complication of reduced kidney functions and limit
           for renoprotection

    • Authors: S.V. Kushnirenko
      Pages: 39 - 46
      Abstract: Hyperphosphatemia in patients with chronic kidney disease (CKD) is an important complication of impaired renal function and is associated with negative clinical consequences such as cardiovascular calcification, bone disease and secondary hyperparathyroidism, which leads to a worsening of cardiovascular di­sease and mortality. The purpose of this review was to discuss the management of hyperphosphatemia in CKD. The following topics are considered: phosphorus homeostasis, diagnosis of hyperphosphatemia, the effectiveness of modern dietary and pharmacological treatment using phosphate binders.
      PubDate: 2020-01-01
      Issue No: Vol. 9, No. 1 (2020)
       
  • Management of refractory lupus nephritis: challenges and opportunities

    • Authors: I.Yu. Golovach, Ye.D. Yehudina
      Pages: 47 - 57
      Abstract: The development of refractory lupus nephritis (LN) indicates an inadequate response to the therapy, which implies the preservation or worsening of the disease activity, despite the the­rapy. However, the definition of LN is ambiguous, given the lack of clear response parameters: the study of proteinuria and renal function does not give a clear difference between activity and irrever­sible damage. Understanding the causes of refractory disease and developing treatment strategies are very important since in such patients the prognosis is extremely unfavourable in the form of the development of the end-stage renal disease. This review explores the current concept of refractory LN and summarizes the treatment approaches used in observational cohort studies and case series. We emphasize the importance of optimizing patient adherence to immunosuppressive and supportive therapeutic strategies, as well as avoiding diagnosis delay. Treatment options include a higher dose of glucocorticoid, switching between cyclophosphamide and mycophenolate mofetil, or adding rituximab, which could potentially be combined with belimumab. Less evidence confirms the effectiveness of extracorporeal treatment (plasma exchange or immunoadsorption), calcineurin inhibitors (cyclosporin A or tacrolimus), intravenous immunoglobulin and stem cell transplantation in the treatment of LN. Improvements in understanding what refractory LN is can be integrated into treatment pathways and improve outcomes of LN
      PubDate: 2020-01-01
      Issue No: Vol. 9, No. 1 (2020)
       
  • Prevention of Contrast Induced Acute Kidney Injury (CI-AKI) In Adult
           Patients

    • Authors: Andrew Lewington, Robert MacTier, Richard Hoefield, Andrew Sutton, David Smith, Mark Downes
      Pages: 58 - 60
      Abstract: No abstract
      PubDate: 2020-01-01
      Issue No: Vol. 9, No. 1 (2020)
       
  • American Diabetes Association Standards of Medical Care in Diabetes
           — 2020

    • Authors: No authors .
      Pages: 61 - 67
      Abstract: No abstract
      PubDate: 2020-01-01
      Issue No: Vol. 9, No. 1 (2020)
       
  • Multimodal imaging of prostate cancer

    • Authors: P.O. Korol, M.M. Tkachenko, O.V. Shcherbina
      Pages: 68 - 79
      Abstract: The literature review presents key issues of the clinical application of multimodal imaging methods in prostate cancer. The world scientific community at the present stage exerts intensive efforts to develop risk stratification tools to help making clinical decisions and optimizing the care of patients with prostate cancer. Multimodal imaging plays a key role in the management of prostate cancer patients for its non-invasive approach to assessing the pre­sence and extent of the primary tumor process, metastatic spread. A promising area of nuclear medicine, theranostics, is being actively introduced into clinical practice. The basic principle of the­ranostics is to “see that you are treating” by combining diagnostic markers with therapeutic radioligands.
      PubDate: 2020-01-01
      Issue No: Vol. 9, No. 1 (2020)
       
  • Hepatitis C virus in patients with chronic kidney disease treated with
           renal replacement therapy

    • Authors: O. Taran
      Pages: 80 - 84
      Abstract: All patients with chronic kidney disease (CKD) must be tested for hepatitis C virus (HCV) infection as the occurrence of HCV infection in those patients is more frequent than in the general population. This is true even for those patients, who do not receive dialysis therapy. It is now known that HCV infection increases the risk of developing CKD and contributes to the progression of CKD. In the absence of sufficient in-depth anti-epidemic measures designed to prevent infection, the latter occurs particularly often in the units performing the renal replacement therapy (RRT). Antiviral treatment is required both for the patients with HCV-associated CKD and the CKD patients at any stage of HCV infection.
      PubDate: 2020-01-01
      Issue No: Vol. 9, No. 1 (2020)
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 18.207.102.38
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-